ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ancef In Sodium Chloride 0.9% In Plastic Container, and what generic alternatives are available?
Ancef In Sodium Chloride 0.9% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ancef In Sodium Chloride 0.9% In Plastic Container
A generic version of ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
Summary for ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
US Patents and Regulatory Information for ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cefazolin sodium | INJECTABLE;INJECTION | 050566-001 | Jun 8, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Baxter Hlthcare | ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cefazolin sodium | INJECTABLE;INJECTION | 050566-002 | Jun 8, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
